References
- Triggle DJ. Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance. Cleve Clin J Med 1992; 59(6): 617–27
- Kaplan NM. Systemic hypertension: therapy. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine. Philadelphia: Saunders, 1992; 852–72
- Henry PD. Calcium channel blockers and atherosclerosis. J Cardiovasc Pharmacol 1990; 16(Suppl 1): S12–5
- Kober G, Schneider W, Kaltenbach M. Can the progression of coronary sclerosis be influenced by calcium antagonists? J Cardiovasc Pharmacol 1989; 13(Suppl 4): S2–6
- Loaldi A, Polese A, Montorsi P, et al. Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris. Am J Cardiol 1989; 64(8): 433–9
- Lichtlen PR, Hugenholtz PG, RaiSenbeul W, et al. Retardation of angiographic progression of coronary artery disease by nifedipine: results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). Lancet 1990; 335(8698): 1109–13
- Waters D, Lespé rance J, Francetich M, et al. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 1990; 82(6): 1940–53
- Borcherding SM, Meeves SG, Klutman NE, et al. Calcium-channel antagonists for prevention of atherosclerosis. Ann Pharmacother 1993; 27(1): 61–7
- Murad F. Drugs used for the treatment of angina: organic nitrates, calcium-channel blockers, and ß -adrenergic antagonists. In: Gilman AG, Rail TW, Nies AS, et al, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990; 764–80
- Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction: results of a double-blind, randomized, multicenter trial. N Engl J Med 1986; 315(7): 423–9
- Wong SC, Greenberg H, Hager WD, et al. Effects of diltiazem on recurrent myocardial infarction in patients with non-Q wave myocardial infarction. J Am Coll Cardiol 1992; 19(7): 1421–5
- Physicians' desk reference. 47th ed. Mont-vale, NJ: Medical Economics Data, 1993: 1581,1841
- Loutzenhiser R, Epstein M, Horton C. Modification by dihydropyridine-type calcium antagonists of the renal hemodynamic response to vasoconstrictors. J Cardiovasc Pharmacol 1987; 9(Suppl 1): S70–5
- Dunselman PH, van der Mark TW, Kuntze CE et al. Different results in cardiopulmonary exercise tests after long-term treatment with felodipine and enalapril in patients with congestive heart failure due to ischaemic heart disease. Eur Heart J 1990; 11(3): 200–6
- Timmis AD, Smyth P, Kenny JF, et al. Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure. Br Heart J 1984; 52(3): 314–20
- Tan LB, Murray RG, Littler WA. Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects. Br Heart J 1987; 58(2): 122–8
- Dunselman PH, Kuntze CE, van Bruggen A, et al. Efficacy of felodipine in congestive heart Mure. Eur Heart J 1989; 10(4): 354–64
- Kassis E, Amtorp O. Long-term clinical, hemodynamic, angiographic, and neurohumoral responses to vasodilation with felodipine in patients with chronic congestive heart failure. J Cardiovasc Pharmacol 1990; 15(3): 347–52
- Cohn JN, Levine TB, Olivan MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311(13): 819–23
- Greenberg BH, Siemienczuk D, Broudy D. Isradipine improves cardiac function in congestive heart failure. Am J Med 1988; 84(Suppl 3B): 56–61
- Packer M, Nicod P, Khandheria BR, et al. Randomized, multicenter, double-blind, placebo-controlled evaluation of amlodipine in patients with mild-to-moderate heart failure. (Abstr) J Am Coll Cardiol 1991; 17(2): 274A
- Gheorghiade M, Hall V, Goldberg AD, et al. Long term clinical and neurohormonal effects of nicardipine in patients with severe heart failure on maintenance therapy with angiotensin converting enzyme inhibitors. (Abstr) J Am Coll Cardiol 1991; 17(2): 274A
- Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm: a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983; 308(11): 619–24
- Gelmers HJ, Gorter K, de Weerdt CJ, et al. A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med 1988; 318(4): 203–7
- Gelmers HJ. The effects of nimodipine on the clinical course of patients with acute ischemic stroke. Acta Neurol Scand 1984; 69(4): 232–9